By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German cancer molecular diagnostics company Epigenomics today reported a 53 percent drop in revenues for the first half of 2010 primarily due to revenues from certain service projects and a collaboration with a major drug firm that were recognized in the year-ago period but not in H1 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.